TY  - JOUR
AU  - Ocaña, Alberto
AU  - Chacon, Jose Ignacio
AU  - Calvo, Lourdes
AU  - Anton, Antonio
AU  - Mansutti, Mauro
AU  - Albanell, Joan
AU  - Martinez, Maria Teresa
AU  - Lahuerta, Ainhara
AU  - Bisagni, Giancarlo
AU  - Bermejo, Begoña
AU  - Semiglazov, Vladimir
AU  - Thill, Marc
AU  - Chan, Arlene
AU  - Morales, Serafin
AU  - Herranz, Jesus
AU  - Tusquets, Ignacio
AU  - Chiesa, Massimo
AU  - Caballero, Rosalía
AU  - Valagussa, Pinuccia
AU  - Bianchini, Giampaolo
AU  - Alba, Emilio
AU  - Gianni, Luca
PY  - 2022
DO  - 10.3389/fonc.2021.827625
SN  - 2234-943X
UR  - http://hdl.handle.net/10668/20678
T2  - Frontiers in oncology
AB  - Derived neutrophil-to-lymphocyte ratio (dNLR) is a biomarker associated with clinical outcome in breast cancer (BC). We analyzed the association of dNLR with pathological complete response (pCR) in triple-negative BC (TNBC) patients receiving...
LA  - en
PB  - Frontiers Research Foundation
KW  - DNLR
KW  - PCR
KW  - Breast cancer
KW  - Immunology
KW  - Neoadjuvant chemotherapy
KW  - Neoadjuvant Therapy
KW  - Neutrophils
KW  - Triple Negative Breast Neoplasms
KW  - Biomarkers
KW  - Tomography, X-Ray Computed
TI  - Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
TY  - research article
VL  - 11
ER  -